Testing staff and surfaces for resistant bacteria in a hospital unit
Part of Infections clinical trials.
This study is for hospital staff in the MDR department. It uses swabs on surfaces and staff to learn how resistant bacteria spread in that ward, which could help protect patients and staff.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a staff member working in the MDR department at Shmuel Harofeh Hospital.
- This includes doctors, nurses, aides, cleaners, or any other role in that unit.
- No other medical conditions or personal health criteria are considered.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether patients in the hospital who carry certain resistant bacteria in their gut are more likely to get infections. The goal is to understand the risk so doctors can better protect you.
This trial monitors healthcare-associated infections and antibiotic resistance by collecting swabs from the nose and rectum while you are hospitalized. It may help doctors better understand how often these infections happen and how to prevent them.
This trial aims to improve how antibiotics are chosen for patients with resistant bacterial infections in the blood. It uses faster diagnostic tests and expert advice to ensure the most effective treatment.
This study looks at wastewater from a hospital to track antibiotic-resistant bacteria. By analyzing these samples, researchers hope to create an early warning system to improve infection control and protect patients.
This study looks at how Klebsiella pneumoniae bacteria that are resistant to many antibiotics form a protective layer (biofilm) and pump out drugs (efflux pump activity). By understanding these mechanisms, doctors may find better ways to treat these tough infections.
This study is looking at bacteria from hospital patients that are hard to treat because they resist many antibiotics, including a last-resort medicine called colistin. By testing these bacteria, researchers hope to find better ways to stop the spread of drug-resistant infections.
Hear when a new Multi Drug Resistant Department trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.